Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
Novartis Animal Health UK has announced a strategic partnership with Procter & Gamble (P&G) Pet Care, maker of the Eukanuba and Iams brands.
As part of the arrangement, the Novartis sales team will start detailing P&G's pet nutrition products to veterinary practices from April 1, 2014 in the UK and at a later stage in Ireland.
Novartis says the partnership brings together two highly complementary portfolios: Novartis is a leader in pet health areas in which P&G's Eukanuba Veterinary Diets have acknowledged strong clinical formulations, specifically dermatology, nephrology, and orthopaedic conditions. The partnership is designed to offer veterinary surgeons a holistic and flexible portfolio in key canine and feline health areas, as well as increased commercial and technical support and partnership from the Novartis sales team.
Simon Harris, sales & marketing manager at Novartis said: "Novartis Animal Health already offers expertise in key companion animal diseases together with innovative veterinary medicines. Based on research done with veterinary customers, we believe nutrition also plays an important role in disease management in pets, making our strategic cooperation with P&G Pet Care a natural fit that offers real benefits to veterinarians and their patients."
Dr. Penny Watson, Senior Lecturer in Small Animal Medicine at the University of Cambridge, said: "Clinical nutrition plays a key role in patient management and is an important complement to medicine in order to achieve a successful outcome. This combination of Eukanuba Veterinary Diets and Novartis Animal Health products helps highlight the importance of dispensing clinical diets as part of a multi-modal approach to effective patient management. Additionally, high quality nutrition is also recommended by vets as part of a normal day-to-day healthy lifestyle."
The partnership will be launched at the BSAVA Congress. The two companies say they'll have a joint presence at the event to showcase the strength and versatility of the combined Novartis and P&G Pet Care portfolio to the veterinary community.
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
The company says it recognises how frustrating it can be for veterinary surgeons if the owner doesn't recognise that their dog has a painful condition. This can be compounded by short consult times, leaving vets unable to fully communicate the implications and treatment options for the disease.
In the video, Zoe encourages vets to tailor their language to each case, in particular, using the language dog owners will use.
While undertaking her research Zoe noticed that many owners do not talk about OA in the same way that vets might; instead of referring to lameness or pain, many owners will refer to the actual physical signs of OA such as stiffness or communicate that their dog is slowing down.
Zoe has also warned that not all owners are convinced by visual demonstrations such as flexing and extending the dogs joints. Instead, she suggests encouraging the owner to get hands-on.
Zoe said: "Point out the visual changes suggestive of osteoarthritis that you can see, such as muscle loss, scuffed nails, and enlarged joints. And encourage them to have a look and a feel, comparing affected and unaffected joints. Hopefully, the owner may be more receptive to the conversation now they associate it with a symptom they can recognise."
Zoe says she also finds that many owners of older dogs often misinterpret the signs of OA as 'just old age' and may not be aware that the condition can be managed effectively with medication, the right exercise, diet and by making modifications in the home.
Elanco has also produced an OA management template which enables both the vet and the owner to create a tailored plan. It provides the owner with information to take away with them about how to modify their home, written in collaboration with Founder of Canine Arthritis Management, Hannah Capon.
Lastly, Zoe recommends a whole practice approach to becoming experts on OA, veterinary nurses in particular. She said: "Vet nurses often have great ideas about how to explain the condition in a way that owners understand. Better owner understanding of OA should lead to better adherence to treatment plans and ultimately better clinical outcomes."
To watch the video, click here.
To access the suite of assets Elanco has created for Onsior (which includes the management plan, social media posts for the practice, and infographic to help owners to spot the signs of OA) visit: www.myelanco.co.uk
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
The Davies Therapy and Fitness Centre has been developed following two years of planning with the intention of supporting referring practices.
Run by a team of Chartered Veterinary Physiotherapists, hydrotherapists and anaesthetists, it has a large hydrotherapy suite, a therapeutic exercise area and gym, an outdoor exercise area, four spacious consultation and treatment rooms and a bright and airy reception.
Services include physiotherapy, rehabilitation, underwater treadmill therapy, soft supports, splinting and orthotics, fitness and conditioning and acupuncture and pain management clinics.
Good rehabilitation is pivotal to the recovery process following injury or surgery and for the management of long-term conditions such as arthritis. DVS says owners are more likely to be compliant with veterinary rehabilitation and fitness programmes if they can fully understand the importance of the process by working with a friendly, professional team, preferably at a bespoke centre.
Diane Messum, Head of Physiotherapy said: "Our mission is to work with referring practitioners to treat every pet, and their owner, with the utmost care and compassion throughout the entire veterinary process. We aim to minimise pain and restore the animals we treat to their maximum physical and mental wellbeing, with the provision of expert therapy, fitness and pain management."
To find out more visit www.vetspecialiststherapy.co.uk
The recall is due to the fact that particulates have been found in identified batches of product during routine stability testing.
The affected batches are:
This issue only applies to the batches listed above. All other batches and the 20 ml pack size are not affected.
For further information regarding the recall, contact Richard Beckwith on 07584 099536 or: richard.beckwith@jurox.co.uk.
The two best research projects were selected on the awards day with Sara Hillyer from the University of Bristol School of Veterinary Sciences winning the £1,000 top prize for her project on vascular endothelial glycocalyx shedding in clinical disease in cats and dogs.
Nicola Mawson from the Royal (Dick) School of Veterinary Studies won the £500 runner-up prize for her project on feline tooth resorptive lesions.
The other four successful candidates were Emily Clark from the University of Nottingham School of Veterinary Medicine & Science, Luca Fortuna from the Royal Veterinary College London, Jessica Lam from the Royal (Dick) School of Veterinary Studies, and Xaquin Castro Dopico from the Royal (Dick) School of Veterinary Studies. Each were awarded £1000 towards their research.
Michelle Townley, Veterinary Advisor and Bursary Co-ordinator at MSD Animal Health said: "We were delighted that we had so many applications this year and again the standard of research and presentation was extremely high. The winning students presented on a very wide range of research areas and selecting just two winners proved extremely hard. It is very encouraging to see such enthusiasm for research in the vets of the future."
Applicants were judged on the quality and clarity of their research project, and their ability to clearly communicate their conclusions.
Applications for the MSD Animal Health Veterinary Student Research Bursary 2018 will be opened early next year. For further information, visit: www.msd-animal-health.co.uk/company-overview/student-research-bursary.aspx
Alstoe is launching Vetergesic Multidose, a 10ml version of the opiate injection, in a new multi-use vial.
Alstoe Technical Director, Dr Ian Ryder said: "In addition to the new vial size the inclusion of a preservative enables Vetergesic Multidose to be used for up to 28 days following its initial use. Also the product is now licensed for intravenous administration."
Vetergesic Multidose should drastically reduce the amount of product wasted by practices using the old, smaller single-use vial.
Alstoe says that supplying Vetergesic in a multi-use vial was one of the first things discussed with the drug originators, Reckitt Benckiser, when it took over the marketing of the product. However, for a large scale medical pharmaceutical manufacturer to consider producing a veterinary product in a different pack and in much smaller production runs than their medical operating scales, the answer is normally no. But in this case, Reckitts gave the project its full support, so in addition to reduced wastage, the inconvenience of snapping glass necks will become a thing of the past.
Please contact Alstoe Ltd for further information at info@alstoe.co.uk or telephone 01347 878606.
Bayer Animal Health has launched Renalzin®, a feed additive for the management of Chronic Renal Disease (CRD), the leading cause of morbidity and mortality, especially in older cats1.
One-third of all cats over 15 years of age have CRD2, but the disease often remains undetected until the cat suddenly falls ill, by which stage 85% of kidney function may have already been lost3. The clinical signs are often subtle and non-specific, and diagnosis is complicated by the fact that changes in laboratory values occur relatively late in the disease.
Dr. Dennis Chew, specialist in veterinary urology and nephrology at the Ohio State University, said: "Most veterinary surgeons understand that CRD affects many cats, especially as they age, and is a leading cause of death. CRD is difficult to identify in early stages - early intervention with treatment can prevent progression of CRD to those with more serious kidney deficits. Restriction of dietary phosphorus intake is known to be a pivotal beneficial step in the stabilisation of CRD. Renalzin is a paste specifically formulated for cats that prevents dietary phosphate absorption across the intestine - a beneficial effect is gained when added to the cat's normal diet or to a veterinary renal diet".
The main ingredient of Renalzin is Bayer-registered Lantharenol® (lanthanum carbonate), a phosphate binder which binds to dietary phosphate within the gastrointestinal tract. According to the company, this renders it indigestible and thereby eases the burden on the already damaged kidneys.
Renalzin contains two additional ingredients - kaolin and vitamin E. Kaolin is a toxin binder which helps to reduce the absorption of toxins from the gastrointestinal tract. Vitamin E is known to reduce free radicals, improving immunity and protecting the integrity of cell membranes.
Bayer says that clinical studies demonstrate that Renalzin significantly increases faecal elimination and decreases urinary excretion of phosphorus 5. The product also decreases phosphate digestibility (absorption) in cats that are on both high and lower phosphate diets6. In addition, studies have shown that Renalzin causes a decrease in serum phosphate levels in cats with standard maintenance diets non-restricted in phosphorus7. Finally, a clinical trial in feline CRD patients revealed that taking Renalzin resulted in improvements in general clinical examination parameters as assessed by their veterinary surgeons over a two month period in cats on a normal diet7.
Renalzin comes in a pump applicator. One pump action provides 1 ml, with 2 ml being the recommended daily dose applied to and/or mixed with the cat's food. Having a neutral taste and being odourless, Renalzin® does not change the flavour of the cat's food and is flexible for clients to use as it can be given once or twice daily depending on the cat's feeding pattern.
References1 Lulich JP, O'Brien TD, Osbourne CA, Polzin DJ. Feline renal failure: questions, answers, questions. Cd Cont Ed Pract Vet 1992, 14(2): 127 - 151.2 Polzin DJ, Osbourne CA, Adams LG, Lulich JP. Medical management of feline chronic renal failure. In, Bonagura JD, Kirk RW (eds). Current Veterinarian Therapy X1. Philadelphia, PA, Saunders, 1992: 848-853.3 Grauer GF. Early detection of renal damage and disease in dogs and cats. Vet Clin Small Animal 2005, 35: 581-596.4 http://en.wikipedia.org/wiki/Lanthanum_carbonate.5 Schmidt B et al Bay 78-1887, J Vet Pharmacol Therap 2006, 29 (Suppl 1): 206-2076 Schmidt B, Spiecker-Hauser U, Gropp J. Effecrt of Lantharenol® on apparent phosphorus absorption from a conventional feline maintenance diet and a renal diet for cats. Proc Soc Nutr Physiol (2008) 17, in press.7 Data submitted for publication.
Finn, a seven-year-old German Shepherd dog, sustained stab wounds to the head and chest as he and his handler, PC David Wardell, pursued a suspect in Stevenage. PC Wardell sustained stab wounds to his hand.
Finn was rushed to Roebuck vets in Stevenage where his wounds were dressed and he was stabilised before being transferred to Davies Veterinary Specialists near Hitchin for emergency surgery.
DVS soft tissue surgeon Rob Adams (pictured above) operated on Finn. He said: "For legal reasons we cannot disclose the full extent of Finn’s injuries. We are however able to confirm multiple knife injuries were sustained to his head and chest involving several of his vital organs. Major surgical intervention was required including open chest surgery to save Finn’s life. Several drains were placed after surgery to manage the degree of trauma and contamination risk from the knife. The surgery went very well and Finn was transferred to intensive care for recovery.
"It is a testament to Finn’s incredible bravery, tenacity and loyalty to his handler, to know he continued to stand firm in the line of duty with no regard to the extent and severity of the injuries he suffered."
DVS says that Finn has exceeded all expectations and recovered very quickly. He has been discharged back into PC Wardell’s care and will hopefully be back up and running again just before Christmas.
PC Wardell said: "I’ve had Finn since he was about nine months old and we’ve been out on the street for just over six years together. It’s just great to have him home. I knew he was in safe hands with Rob Adams but because of the extent of his injuries I was so worried I was going to lose him. Finn’s not only my loyal partner at work but he’s also a part of our family. He has a home for life with me - I can’t imagine life without him."
Meanwhile, a campaign is underway to give police dogs and horses the same status as officers if they are injured in the line of work, so that people who attack police animals face charges similar to those for attacking a person.
You can sign the 'Finn's Law Petition' here: https://petition.parliament.uk/petitions/168678
The campaign also has a twitter feed here: https://twitter.com/FinnsLaw
Asked why the CMA had decided to launch the review, its Senior Director for Consumer Protection told BBC R4's Today programme this morning that: "the costs of many vet services are rising higher than the cost of inflation, and it can be really hard to find out how much it's going to cost you, both for routine treatments or if something goes wrong and you need to find emergency care for your pet."
George added: "There's many other [veterinary] services and costs that people cannot have predicted and they can find themselves unexpectedly facing some really high bills, and when other household bills are going up very steeply at the moment we want to do everything we can to make sure that people can predict how much it is going to cost to see a vet, both for routine stuff but also for things if there's a crisis."
The authority is also looking at whether there is enough transparency over practice ownership.
With the percentage of independent practices falling from 89% in 2013 to 45% by 2021, the authority says people may not be clear if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group.
This, it says, could impact pet owners’ choices and reduce the incentives of local vet practices to compete.
The CMA is now asking veterinary professionals, people who supply veterinary products and services and pet owners to take part in the review by completing an online questionnaire: https://www.gov.uk/guidance/how-to-respond-to-the-veterinary-services-market-for-pets-review
In particular, it wants to hear practitioners' experiences of:
The questionnaire will remain open for six weeks.
The CMA will outline the issues it identifies and announce its next steps early in 2024.
The BSAVA Guide to the Use of Veterinary Medicines has been developed to help veterinary professionals navigate the regulations, changes and issues that face the profession when it comes to the use of veterinary medicines.
Edited by David Harris and Pam Mosedale, there are three new sections which cover:
The BSAVA also highlights that the law in the UK relating to the use of veterinary medicines will be updated when the VMD completes its review.
In addition changes to the RCVS Code of Conduct concerning under care are due to come into force in September.
This, the Association says, will lead to significant changes in medicines use, as well as legal and ethical dilemmas.
As a result, the new guide includes a section at the beginning of the Guide that will be updated as required and the editors encourage all veterinary professionals to stay up to date with the progress of these reviews.
The new BSAVA Guide to the Use of Veterinary medicines is freely available to all via the BSAVA Library.
The publishers say that with a global donkey population estimated at around 46 million, it’s imperative for the veterinary profession to stay well-informed about the unique biology and disease susceptibility of this species.
The virtual collection addresses the previous shortfall of pathophysiological information, with articles on pharmacology, diagnostics, disease prevalence and management practices relating to donkeys as working, companion and production animals.
Preventative healthcare is addressed with a study of a companion population of donkeys in the UK and clinicians are encouraged to focus on client education, promotion of vaccination, regular dental care, strategic parasite control programmes and weight management.
Several papers address decision-making around treatment options, emphasising the need for a good understanding of the pharmacology of the available therapeutic agents in relation to donkeys and the pathophysiology of the diseases, as well as the value of pain assessment and control.
Another important aspect of disease detection and management is the availability of accurate diagnostics. Several papers address aspects of diagnostic testing, with emphasis on the caution that must be taken when extrapolating from horses because of the minimal data relating specifically to donkeys.
Donkeys are often described as silent carriers of, or as being more resistant to, infectious agents. Two articles demonstrate that they can in fact develop severe clinical signs when exposed to certain known equine pathogens, raising the importance of surveillance, accurate diagnosis, outbreak management, disease control and clear communication and education.
Less common conditions in donkeys as well as awareness of zoonotic risk are addressed within the collection, emphasising the value of owner-driven reporting as part of a disease surveillance and control programme to inform decision making on relevant interventions.
Professor Celia Marr, Editor of the EVJ, said: “This impressive collection shines a spotlight on the important advances that have been made to donkey medicine and welfare and helps us to identify the research gaps yet to be filled
“By sharing this work, we aim to improve disease prevention and enhance the welfare of donkeys around the world as well as highlight the continued importance of owner education and improve the public perception of this enduring species.”
The virtual issue can be found here: https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.donkey-medicine-welfare.vi
The Royal College of Veterinary Surgeons has announced the results of the 2011 RCVS and VN Council elections.
Elected to the RCVS Council are:
Not elected are:
For the first time in eight years, all six successful RCVS Council candidates have served on Council before, although one - Sandy Trees - is currently an appointed, rather than an elected, member.
For VN Council, one existing member has been returned and two new members have been elected:
Not elected to VN Council was:
Following rises in previous turnouts, voting figures have dropped markedly this year in both RCVS and VN Councils elections, to 15.9% (3,887 voters) and 7.6% (723 voters) respectively. The previous turnouts were 18.8% (in 2010) and 11.2% (in 2009).
RCVS Registrar Jane Hern said: "It's certainly disappointing that the turnout has dropped so much this year. It's unclear whether this is due to lack of time, lack of awareness, or lack of interest, but perhaps anyone who didn't vote could let us know why, so we can see what we could do to increase participation.
"Nevertheless, my congratulations to all successful candidates, who I look forward to formally welcoming, or welcoming back, onto the Councils at RCVS Day in July, and my commiserations to those who were unsuccessful this time and who I hope won't be discouraged from standing again next year."
This year's chosen charity - the Veterinary Benevolent Fund - will receive a cheque for £922 arising from the College's pledge to donate 20p for each veterinary surgeon and veterinary nurse who cast a vote.
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.
The new study, which was conducted by the RVC's VetCompass Programme found that 33% of deaths in dogs aged under 3 years (roughly 21,000 dog deaths in the UK) are caused by undesirable behaviours which may reflect poor training by owners, or be caused by undiagnosed medical conditions.
The study also found that male dogs and smaller dogs were more likely to die from undesirable behaviours than female or larger dogs and that certain breeds were hugely predisposed.
It is hoped that this research can raise awareness of the most common undesirable behaviours in dogs and encourage owners to improve the health and welfare of their animals through better choices when getting a puppy and improved training afterwards.
The RVC conducted this study using its analytics programme, VetCompass, to explore the de-identified data of a quarter of a million dogs in the UK.
From this data, the researchers identified 1,574 dogs that had died before the age of 3 years.
Analysing the patterns of deaths, they found that:
33.7% of all deaths in dogs (or roughly 21,000) aged under 3 years in the UK are due to undesirable behaviours
The most common undesirable behaviours that led to death were aggression (54.0% of deaths) and road traffic accident [which may have behavioural components such as straying and poor recall] (39.0% of deaths).
Crossbred dogs were 1.4 times more likely to die from an undesirable behaviour than purebred dogs.
Dogs weighing under 10 kg were more than twice as likely to die from an undesirable behaviour as dogs weighing over 40 kg.
Compared with the Labrador Retriever, the breeds with the highest risk of death from an undesirable behaviour were the Cocker Spaniel (8 times the risk), West Highland White Terrier (5.7 times the risk), Staffordshire Bull Terrier (4.5 times the risk), and Jack Russell Terrier (2.7 times the risk). The Labrador Retriever was chosen as the baseline breed as it is a common and well-known breed.
Male dogs were 1.4 times more likely to die from an undesirable behaviour than females.
Of the dogs that died from an undesirable behaviour, the owners of 12.9% dogs had sought veterinary behavioural advice.
Behavioural drug therapy was used in 3% of dogs that died from an undesirable behaviour.
12.2% of dogs that died from an undesirable behaviour had been previously rehomed.
76.2% of the dogs that died from an undesirable behaviour were euthanised (i.e. put to sleep).
The paper raises severe concerns about the high numbers of dogs that are put to sleep due to undesirable behaviours which accounts for over three-quarters of all dogs that die from undesirable behaviours.
Dr. Dan O'Neill, Senior Lecturer at the RVC and supervisor of the study, said: "This study is the biggest study ever undertaken on behavioural reasons for deaths in young dogs in the UK.
"It suggests the importance of good socialisation of puppies by breeders, of sensible breed selection by owners and of careful dog training after acquiring a dog, to ensure that the lives of dogs and owners are fulfilling for all parties involved.
"Dogs with behaviours that their owners find unacceptable are at risk of compromised welfare, either because of their own underlying emotional motivations for the behaviour (e.g. anxiety or fear) or because of how their owners might seek to resolve the problem (e.g. the use of punishment such as beating or electric shock collars).
"Greater awareness of the scale of this issue can be the first step towards reducing the problems and making the lives of thousands of our young dogs happier."
Reference
The clinic is being run by Liz Leece, an RCVS and EBVS Specialist in veterinary anaesthesia and analgesia, to offer bespoke pain management plans for clients.
Liz has more than 20 years’ experience in specialist anaesthesia and analgesia and has extensive experience managing dogs and cats with complex problems causing chronic pain.
Liz said: "Our pets are similar to humans in the sense that the longer they live, the greater the chance they will develop conditions causing chronic pain.
"The clinic is available for any pet referred by their primary care vet for management of chronic pain, including osteoarthritis and other orthopaedic conditions, neurological and cancer pain.
"Animals will be assessed and advice given on how the pain can be managed, including monitoring a pet’s response to different treatments and what to expect."
For more information, visit www.paragonreferrals.co.uk.
The event is being held in the Bath Assembly Rooms, right in the heart of the city, on Thursday 21st and Friday 22nd September 2017.
Organiser Simon Guiton MRCVS said: "The programme is based on current hot topics for veterinary surgeons and nurses. We've got a great line up of speakers, not to mention everything else that Bath has to offer by way of culture, restaurants and shopping. It sure beats Milton Keynes on a wet Friday afternoon!"
The programme for veterinary surgeons is as follows:
Day One
Day Two
Speakers include Emi Barker, Esther Barrett, Kieran Borgeat, Gwen Covey-Crump, Angie Hibbert, Nicola Kulendra, Shasta Lynch, Natasha Mitchell, Kostas Papasouliotis, Anita Patel, Louise O’Dwyer, Denise Prisk, Suzanne Rudd, Claire Woolford and Holly Witchell.
Early bird tickets on sale at £139 +VAT for one day, £249 +VAT for both days until 30th June.
For more information, visit: http://vetcpdcongress.co.uk
Somerset vet Stewart Halperin MRCVS has launched CarefreeCredit, a service designed to help pet owners pay for unforeseen veterinary bills, and take the burden of unpaid bills away from veterinary surgeons.
The new service is very simple. First, participating practices need to apply to CarefreeCredit and register with the Financial Conduct Authority (FCA). CarefreeCredit will hold your hand through the FCA registration process, which is currently taking about three weeks.
Thereafter, you can then offer CarefreeCredit to any client who is faced with an unexpected bill which they can't pay immediately. They'll need to make an online application which can be done at any time of day, 365 days a year - crucial for out-of-hours emergencies. The application takes 4 minutes and decisions are instant.
Loans repaid over 12 months are interest-free for the pet owner. Loans repaid over 24 months attract interest at 7.9% APR.
Once the loan is approved, confirmation is sent to the veterinary practice, which can then drawdown the funds into the practice bank account via the CarefreeCredit online dashboard. The practice gets paid within 5 days of requesting a drawdown.
The cost to the practice of all this is 7% of the bill. Offered strategically to the right clients, that seems like a small price to pay. According to CarefreeCredit, practice revenue increases by 22% and debtors decrease by 58% in practices where finance facilities are offered. But that is, of course, only half the story. This also offers a professional and businesslike 'way out' when vets are at the receiving end of emotional blackmail (or worse) from clients who find they don't have the money to pay for their much-loved pet to get the medical care it needs.
Stewart, himself the owner of a six-practice business, said: "The only way a credit facility like this works is that if it is so simple to use that front office staff see it as a help rather than a hindrance - a tool to make their lives easier rather than just another piece of admin to do. In order to get to this point, we have been through discussions with a number of consumer credit institutions as well as major retail banks. The system we can now provide is the market leader by a long way. The great thing is, vets love it as they can do gold standard work, get paid properly for it and receive the funds straight away. Owners love it as they can spread the cost at no or very low cost to themselves - and of course, the pets get treated immediately!"
For more information, visit: www.carefreecredit.co.uk
The BSAVA has announced the launch of a free new online publication: BSAVA Guide to the Use of Veterinary Medicines
Edited by Fred Nind and Pam Mosedale, with contributions from experts in the field, has been developed to provide a comprehensive guide to a wide variety of veterinary medicines issues that affect small animal practice. It looks like a very polished production, and should prove a valuable tool for all members of the practice team.
Many infringements of the law relating to the possession, use and disposal of veterinary medicines are criminal offences, and it was the aim of the Editors to produce an authoritative guide to help practitioners stay on the correct side of the law in an area where this can sometimes be problematic.
LegislationAs Fred and Pam noted in the March 2009 issue of Companion: 'Veterinary Medicines Regulations (VMR) change every year, whilst waste disposal provisions and dangerous drugs regulations seem to be updated even more often. This means that what you learned at a course attended last year or from a booklet published two years ago may no longer be accurate.' The format of the BSAVA Guide to the Use of Veterinary Medicines, means that it is capable of being updated as the rules and regulations change, helping veterinary surgeons, nurses, practice managers, receptionists, students and kennel staff to get it right - first time and every time.
StorageEfficient stock control, ambient storage conditions, stock rotation based on expiry dates and correct labelling are just some of the areas that need to be addressed when considering management of the practice dispensary. The section of the guide on Correct storage and dispensary management provides recommendations on how this can be achieved.
DispensingPrescribing and labelling veterinary medicines are activities that every practitioner performs many times a day, and it is important that the detailed legal provisions governing these actions are adhered to. Covering such areas as: who may write a prescription; breaking packaging; and the additional regulations that apply for the supply of Controlled Drugs, the Prescribing and labelling section helps guide the practitioner through this complicated area.
The BSAVA Guide to the Use of Veterinary Medicines is available to all, not just BSAVA members, and the Editors hope will 'provide balm for all those worrying about the practical and legal constraints on the use of veterinary medicines.'
Click here to download the BSAVA Guide to the Use of Veterinary Medicines (pdf 5mb)
The online seminar, which equates to one hour’s CPD, features six UK experts in equine endocrinology, with the objective of supporting equine and mixed practice vets in using the clinical history to guide their interpretation of the basal ACTH test results and subsequent treatment decisions.
The speakers participating in the Equine Endocrine Pioneers Circle are:
Harry Carslake MA VetMB DipACVIM MRCVS: Senior lecturer in equine medicine at the University of Liverpool
Edd Knowles MA VetMB MVetMed DipECEIM MRCVS: Specialist in Equine internal medicine at Bell Equine Veterinary clinic
Professor Cathy McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS: Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool
Dr Nicola Menzies-Gow MA VetMB PhD DipECEIM Cert EM(Int Med) MRCVS: Reader in equine medicine at the Royal Veterinary College
Victoria South MA VetMB CertAVP(EM) DipECEIM MRCVS: Senior assistant at Liphook Equine Hospital
Nicola Steele BVM&S CertAVP(EM) MRCVS: Fyrnwy Equine Clinic and Director of Veterinary CPD (Equine and Large Animal)
The webinar considers when vets should test for PPID and decision-making on the best test to use, how to interpret grey zone results and also how to interpret problematic follow up tests. The experts have different opinions on some of these areas, allowing vets in practice to see the different ways in which cases can be viewed and managed.
These principles are then reinforced by the use of three clinical case scenarios with the patients all having the same basal ACTH result but a different selection of clinical signs.
Liz Barrett, equine business head at Boehringer Ingelheim said: "Since the launch of our Talk About Laminitis initiative in 2012, more than 50,000 horses have benefited from complimentary basal ACTH tests to aid the diagnosis of PPID, however two common areas of uncertainty in interpreting ACTH results still exist. Firstly, the interpretation of borderline, equivocal or ‘grey-zone’ results and when PPID treatment should or shouldn’t be recommended and secondly, the interpretation of follow-up ACTH test results and when to advise altering the treatment dose.
"The Equine Endocrine Pioneers Circle webinar allows vets to update their knowledge on this broad subject area and illustrates that there is often more than one way to approach the diagnosis, treatment and management of the PPID case."
To view the Equine Endocrine Pioneers Circle webinar on the Boehringer Academy visit https://www.boehringer-academy.co.uk/webinar/bil205
Sean became interested in animal welfare science as an undergraduate veterinary student, when he was awarded a Universities Federation for Animal Welfare (UFAW) Vacation Scholarship to investigate the welfare of caged zebra finches housed under typical pet shop conditions.
Six years later, having been instrumental in developing BVA policy in supporting a ban on the importation of wild-caught birds into the European Union to be kept as pets, Sean represented the position in Brussels and an EU-wide ban was introduced in 2007.
As BVA President in 2015/16, Sean initiated and led the production of BVA’s Animal welfare strategy. Developed through consultation with representatives from across the profession and other sector stakeholders, 'Vets speaking up for animal welfare' lays out a number of strategic actions based on the veterinary profession’s unique opportunity and responsibility to advocate animals' best interests at individual, community and political levels.
The strategy aims to further expand BVA’s animal welfare advocacy; provide tools and support to BVA members in areas such as veterinary ethics; and foster collaboration with other animal welfare-focused partners such as the recently launched BVA/British Cattle Veterinary Association (BCVA) position paper promoting analgesic use alongside local anaesthesia for routine surgical procedures on calves. To help build BVA’s international animal welfare agenda, Sean has recently been appointed as a member of the FVE Animal Welfare Working Group.
Another important project during Sean’s BVA Presidency was the jointly led BVA/RCVS Vet Futures project. He assisted in developing the Vet Futures report, which identifies veterinary leadership in animal health and welfare as one of the six key ambitions in its 2030 vision for the veterinary profession. While President he also produced an online video with the international animal welfare organisation World Animal Protection on the importance and relevance of animal sentience to the veterinary profession.
British Veterinary Association President Gudrun Ravetz, said: "Improving animal welfare has always been the focus of Sean’s veterinary career, through veterinary practice and policy and developing the profession’s role in advancing animal welfare. Since his undergraduate research and subsequent postgraduate studies in animal welfare, he has undertaken a wide range of overseas volunteer projects and continues to champion and promote understanding of animal welfare at individual, community, national and international levels on a daily basis.
"Sean also led on BVA’s landmark Animal welfare strategy, championing the role of vets as advocates of animals’ best interests and sending a clear signal that the veterinary profession will be a considerable force for good, for animals and for an increasingly compassionate society in the years ahead.
"Sean has made a difference to the lives of many animals with his dedication to animal welfare. I am delighted that Sean is being recognised on an international stage for his fantastic work in the field of animal welfare with this important award."
On receiving his award, Sean said: "It is excellent that WVA has further underpinned its commitment to animal welfare, in line with global society’s expectation of our profession as animal welfare leaders, through the establishment of the Global Animal Welfare Awards. It’s a great honour to be a recipient, which is tribute to my driven and forward-looking colleagues at BVA and PDSA. I thank them, as well as the many other organisations, institutions and individuals who have given me invaluable opportunities and encouragement during my career to date."
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal for cattle and sheep will be extended to 70 days and pigs to 77 days. For Micotil, sheep milk withdrawal will be extended to 18 days and milk from cows during the dry period or from pregnant heifers should not be used for human consumption until 36 days after calving.
Elanco is reminding veterinary surgeons and SQPs that they may continue to prescribe according to the current label but it is good practice to implement revised withdrawal periods. The company is also taking this opportunity to highlight the importance of getting into the habit of double-checking withdrawal periods when administering drugs, because they do change from time to time in the light of new knowledge.
The Disciplinary Committee heard that Mrs Garfield had told a representative of the Retired Greyhound Trust (RGT) that she had possession of a greyhound called Lola, that she proposed keeping Lola living with her as an adoptee, and that she would not relinquish possession of Lola except to the RGT. This was despite the fact that, at the time of signing the adoption agreement, she had already given Lola to another charity named Greyhound Gap and that, as a result, her conduct was misleading and dishonest.
In considering the facts of the case, the Committee found the charges and all constituent parts proven and went on to consider whether this amounted to disgraceful conduct in a professional respect.
Judith Way, chairing the Committee and speaking on its behalf, said: "The end result of the respondent’s decisions and conduct meant that RGT was persuaded to pass lawful possession and ownership of the dog Lola to the respondent when it would not have agreed to do so had it been told the truth by her.
"In truth, the respondent was not going to adopt and re-home Lola herself. Instead the respondent’s plan and intention was that Lola should be passed on to a third party who had been recommended by a rival dog rescue charity for rehome and adoption."
Judith added: "The consequence was that a social media dispute broke out when the rival dog charity decided to attempt to take advantage of the erroneous belief of the respondent that a decision had been taken by RGT to put Lola to sleep. The publicity generated by the respondent’s erroneous belief… was obviously adverse…. The gravamen [seriousness] of the respondent’s dishonest conduct was that she set one dog rescue charity against another, caused them to spend publicly raised funds on a legal dispute about who should be allowed to retain Lola when those precious funds ought, instead, to have been spent on their charitable objectives."
The Committee judged that the charge and its parts constituted serious professional misconduct and went on to consider the sanction against Mrs Garfield.
In considering the proportionate sanction the Committee took into account both mitigating and aggravating factors. In terms of aggravating factors the Committee considered that the dishonesty was pre-meditated, that she accused members of a rescue charity of lying and demonstrated no or only minimal insight into her wrongdoing. In mitigation the Committee considered that Mrs Garfield had cooperated with the College in its investigations, that she had acted in the genuine belief that she was acting in the best interests of Lola and that her conduct did not put Lola at risk or cause her to suffer any adverse consequences as a result. The Committee also accepted the testimonials and positive evidence from colleagues.
However, the Committee decided that removal from the Register would be the only appropriate sanction.
Summing up Judith Way said: "The reputational consequences for RGT were potentially significant bearing in mind that it is a rescue organisation with some 57 or so branches across the country. All of these consequences, actual and potential, stem from the respondent’s premeditated act of dishonesty in relation to which the Committee considers she showed very limited insight prior to this disciplinary hearing, as she did during the course of this hearing.
"In the result, it is the conclusion and decision of this Committee that the only proper sanction that can be imposed in this case is that the respondent’s name should be removed from the Register.”
Mrs Garfield has 28 days from being informed of the Committee’s decision to appeal.